Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU Topicscardiovascular

ICU · cardiovascular

Acute decompensated heart failure — comprehensive ICU management (ADHF, cardiogenic shock overlap)

Also known as ADHF · Acute heart failure · Cardiogenic pulmonary oedema · Flash pulmonary oedema · Acute decompensated heart failure · Cardiogenic shock · Warm and wet · Cold and wet · Stevenson classification · Nohria profiles · DOSE trial · CARRESS-HF · 3CPO trial · ADHERE registry · ADVOR trial

Acute decompensated heart failure (ADHF): an admission for worsening heart failure producing congestion and/or hypoperfusion. CLASSIFICATION (Nohria/Stevenson bedside profiles): congestion (WET vs DRY) x perfusion (WARM vs COLD); in the 452-patient cohort wet-warm n=222, wet-cold n=91, dry-warm n=123, dry-cold n=16, and the congested profiles predicted death or urgent transplant. PRECIPITANTS (OPTIMIZE-HF): pneumonia/respiratory process, ischaemia, arrhythmia, uncontrolled hypertension, non-adherence and worsening renal function. MANAGEMENT: oxygen only if hypoxaemic, early NIV for respiratory distress (3CPO: faster dyspnoea and metabolic improvement, no 7-day mortality difference), IV loop diuretic (DOSE) with early response assessment (HFA), IV vasodilators when SBP over 110 mmHg (ESC 2021; Cotter high-dose nitrate), noradrenaline over dopamine in cardiogenic shock (SOAP II), selective short-term MCS (IABP-SHOCK II, ECLS-SHOCK, DanGer Shock), ultrafiltration not first-line (CARRESS-HF), avoid routine morphine (ADHERE), continue beta-blockers where possible (meta-analysis) and up-titrate GDMT rapidly after discharge (STRONG-HF).

high24 referencesUpdated 20 Aug 202618 min readSource-verified · Oct 2026

Checked against its sources on 8 Oct 2026

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Classify first: the Nohria/Stevenson profile (warm/cold x wet/dry) — congested profiles B and C carried a multivariate HR 2.48 for death or urgent transplant.
  • Cold and wet with low SBP and hypoperfusion = cardiogenic shock: noradrenaline over dopamine (SOAP II: more arrhythmia and more cardiogenic-shock deaths with dopamine) plus an inotrope, with specialist MCS decisions.
  • NIV as soon as possible for respiratory distress (RR over 25, SpO2 under 90%) — 3CPO: faster dyspnoea and metabolic improvement, no short-term mortality difference.
  • Assess diuretic response early: spot urine sodium under 50-70 mEq/L at 2 h and/or urine output under 100-150 mL/h in the first 6 h signals an insufficient response (HFA).
  • IV vasodilators only when SBP is over 110 mmHg; never in the hypotensive, hypoperfused patient.
  • Ultrafiltration is NOT first-line — CARRESS-HF: worse creatinine, similar weight loss, more serious adverse events.
  • Avoid routine morphine (ADHERE analysis: more ventilation, ICU admission and mortality) and routine inotropes in the non-hypoperfused patient (OPTIME-CHF, PROMISE).
  • Venous congestion, not low output, is the haemodynamic factor most associated with worsening renal function (Mullens) — keep decongesting while the patient is still congested.
  • Continue beta-blockers if the clinical picture allows (withdrawal associated with higher in-hospital mortality) and up-titrate GDMT rapidly after discharge (STRONG-HF).
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Classify first: the Nohria/Stevenson profile (warm/cold x wet/dry) — congested profiles B and C carried a multivariate HR 2.48 for death or urgent transplant.
  • Cold and wet with low SBP and hypoperfusion = cardiogenic shock: noradrenaline over dopamine (SOAP II: more arrhythmia and more cardiogenic-shock deaths with dopamine) plus an inotrope, with specialist MCS decisions.
  • NIV as soon as possible for respiratory distress (RR over 25, SpO2 under 90%) — 3CPO: faster dyspnoea and metabolic improvement, no short-term mortality difference.
  • Assess diuretic response early: spot urine sodium under 50-70 mEq/L at 2 h and/or urine output under 100-150 mL/h in the first 6 h signals an insufficient response (HFA).
  • IV vasodilators only when SBP is over 110 mmHg; never in the hypotensive, hypoperfused patient.
  • Ultrafiltration is NOT first-line — CARRESS-HF: worse creatinine, similar weight loss, more serious adverse events.
  • Avoid routine morphine (ADHERE analysis: more ventilation, ICU admission and mortality) and routine inotropes in the non-hypoperfused patient (OPTIME-CHF, PROMISE).
  • Venous congestion, not low output, is the haemodynamic factor most associated with worsening renal function (Mullens) — keep decongesting while the patient is still congested.
  • Continue beta-blockers if the clinical picture allows (withdrawal associated with higher in-hospital mortality) and up-titrate GDMT rapidly after discharge (STRONG-HF).
The one-paragraph fellowship answer

Acute decompensated heart failure (ADHF) is assessed at the bedside on two axes — congestion (wet or dry) and perfusion (warm or cold) — and those Nohria/Stevenson profiles predict outcome. The wet-warm patient (the largest profile in the Nohria cohort) gets an IV loop diuretic with early response checks, plus an IV vasodilator if SBP is over 110 mmHg; the wet-cold patient with low SBP and hypoperfusion is in cardiogenic shock and gets an inotrope, noradrenaline in preference to dopamine, and a specialist decision about short-term MCS; NIV starts as soon as possible for respiratory distress. Then treat the precipitant, continue beta-blockers if the clinical picture allows, and up-titrate GDMT rapidly after discharge.[3][24][8][20][21]

Meet the patient

A 72-year-old man with known HFrEF (LVEF 28 per cent) sits bolt upright on the ward, grey, sweating, respiratory rate 36, SpO2 86 per cent on a simple mask. He ran out of his bisoprolol and sacubitril-valsartan a week ago. Bedside: SBP 168, warm peripheries, JVP to the ear, bibasal crackles — a warm-wet profile, the commonest group in the Nohria cohort. Respiratory rate over 25 and SpO2 under 90 per cent: NIV goes on now.[3][24]

The question that decides the next drug is the one that decides every ADHF admission: is this patient wet or dry, and warm or cold? Hold that 2x2 and every infusion below slots into place.[3]

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References24ShowHide
  1. [1]Adams K F Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J, 2005.PMID 15846257
  2. [2]Fonarow GC, Adams K F Jr, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA, 2005.PMID 15687312
  3. [3]Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure J Am Coll Cardiol, 2003.PMID 12767667
  4. [4]Gray A, Goodacre S, Newby DE, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema N Engl J Med, 2008.PMID 18614781
  5. [5]Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure N Engl J Med, 2011.PMID 21366472
  6. [6]Mullens W, Damman K, Harjola VP, et al. The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail, 2019.PMID 30600580
  7. [7]Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome N Engl J Med, 2012.PMID 23131078
  8. [8]De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock N Engl J Med, 2010.PMID 20200382
  9. [9]Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock N Engl J Med, 2012.PMID 22920912
  10. [10]Peacock WF, Hollander JE, Diercks DB, et al. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis Emerg Med J, 2008.PMID 18356349
  11. [11]Cotter G, Metzkor E, Kaluski E, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema Lancet, 1998.PMID 9482291
  12. [12]Long B, Brady WJ, Gottlieb M, et al. Emergency medicine updates: Sympathetic crashing acute pulmonary edema Am J Emerg Med, 2025.PMID 39799613
  13. [13]Cuffe MS, Califf RM, Adams K F Jr, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial JAMA, 2002.PMID 11911756
  14. [14]Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group N Engl J Med, 1991.PMID 1944425
  15. [15]Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure J Am Coll Cardiol, 2009.PMID 19215833
  16. [16]Shahverdi E, Shahverdi A, Schneider C, et al. Optimization and Real-World Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: A Contemporary Clinical Review Cardiol Res, 2026.PMID 42016211
  17. [17]Guidi JL, Allen BR, Headden G, et al. A novel NT-proBNP assay for heart failure diagnosis: A prospective, multicenter clinical trial Clin Chim Acta, 2025.PMID 40107595
  18. [18]Mullens W, Dauw J, Martens P, et al. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload N Engl J Med, 2022.PMID 36027559
  19. [19]Fonarow GC, Abraham WT, Albert NM, et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Archives of internal medicine, 2008.PMID 18443260
  20. [20]Prins KW, Neill JM, Tyler JO, et al. Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis. JACC. Heart failure, 2015.PMID 26251094
  21. [21]Mebazaa A, Davison B, Chioncel O, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet (London, England), 2022.PMID 36356631
  22. [22]Thiele H, Zeymer U, Akin I, et al. Extracorporeal Life Support in Infarct-Related Cardiogenic Shock. The New England journal of medicine, 2023.PMID 37634145
  23. [23]Møller JE, Engstrøm T, Jensen LO, et al. Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock. The New England journal of medicine, 2024.PMID 38587239
  24. [24]McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European heart journal, 2021.PMID 34447992

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAcute coronary syndromes (STEMI, NSTEMI, unstable angina)CardiovascularNextAcute decompensated heart failure and cardiogenic pulmonary oedemaCardiovascular